Bruker supports COVID19-NMR Consortium

By The Science Advisory Board staff writers

August 10, 2020 -- Bruker is highlighting its support of a global project called COVID19-NMR that will investigate the structure, dynamics, function, and binding of SARS-CoV-2 viral RNA and proteins using nuclear magnetic resonance (NMR) spectroscopy.

Goethe University in Frankfurt, Germany, initiated the project. It includes a consortium of 30 organizations in 15 countries and will explore the potential of small molecule drugs to bind to the virus's biopolymer structures, Bruker said.

Bruker releases MALDI-2 to advance mass spectrometry
Bruker announced a major advance in matrix-assisted laser desorption ionization (MALDI) with the launch of the world's first commercial MALDI-2 postionization...
Bruker launches plethora of new products online
Bruker is showcasing a number of its new analytical systems and other products for biopharma and forensics applications. The products include a new gas...
Bruker launches new microscopy technology
On Monday, December 10, at the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO) meeting, Bruker introduced...
Bruker & Murdoch University strategic collaboration announced for phenomics
On Friday, September 20, 2019, Murdoch University (Perth, Australia) and Bruker (Billerica, Massachusetts) announced a strategic collaboration to transform...

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter